Royal Bank of Canada’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $128K | Sell |
4,063
-14,056
| -78% | -$443K | ﹤0.01% | 5133 |
|
|
2025
Q1 | $602K | Sell |
18,119
-4,200
| -19% | -$140K | ﹤0.01% | 3529 |
|
|
2024
Q4 | $768K | Buy |
22,319
+17,635
| +376% | +$607K | ﹤0.01% | 3332 |
|
|
2024
Q3 | $187K | Sell |
4,684
-7,384
| -61% | -$295K | ﹤0.01% | 4432 |
|
|
2024
Q2 | $364K | Sell |
12,068
-16,317
| -57% | -$492K | ﹤0.01% | 3894 |
|
|
2024
Q1 | $953K | Sell |
28,385
-4,338
| -13% | -$146K | ﹤0.01% | 3115 |
|
|
2023
Q4 | $1.06M | Buy |
32,723
+14,017
| +75% | +$453K | ﹤0.01% | 3152 |
|
|
2023
Q3 | $614K | Buy |
18,706
+6,869
| +58% | +$225K | ﹤0.01% | 3409 |
|
|
2023
Q2 | $417K | Buy |
11,837
+4,063
| +52% | +$143K | ﹤0.01% | 3692 |
|
|
2023
Q1 | $254K | Sell |
7,774
-2,705
| -26% | -$88.4K | ﹤0.01% | 4058 |
|
|
2022
Q4 | $577K | Buy |
10,479
+4,679
| +81% | +$258K | ﹤0.01% | 3550 |
|
|
2022
Q3 | $257K | Buy |
5,800
+4,983
| +610% | +$221K | ﹤0.01% | 4084 |
|
|
2022
Q2 | $40K | Sell |
817
-1,425
| -64% | -$69.8K | ﹤0.01% | 5353 |
|
|
2022
Q1 | $109K | Sell |
2,242
-2,601
| -54% | -$126K | ﹤0.01% | 5114 |
|
|
2021
Q4 | $206K | Buy |
4,843
+1,586
| +49% | +$67.5K | ﹤0.01% | 4790 |
|
|
2021
Q3 | $125K | Buy |
3,257
+964
| +42% | +$37K | ﹤0.01% | 5044 |
|
|
2021
Q2 | $65K | Buy |
2,293
+1,623
| +242% | +$46K | ﹤0.01% | 5373 |
|
|
2021
Q1 | $22K | Buy |
670
+614
| +1,096% | +$20.2K | ﹤0.01% | 5867 |
|
|
2020
Q4 | $2K | Buy |
+56
| New | +$2K | ﹤0.01% | 6298 |
|